Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Human IL-28B/IFN-lambda 3 Antibody, R&D Systems™
GREENER_CHOICE

Mouse Monoclonal Antibody

Supplier:  R&D Systems MAB52593SP

 View more versions of this product

Catalog No. MAB52593SP


Only null left
Add to Cart
This item is not returnable. View return policy

Description

Description

IL-28B/IFN-lambda 3 Monoclonal specifically detects IL-28B/IFN-lambda 3 in Human samples. It is validated for ELISA.
Specifications

Specifications

IL-28B/IFN-lambda 3
Monoclonal
Unconjugated
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.
interleukin-28B, IFN-lambda 3, IL28B, IL-28B, IL28C, interferon, lambda 3
Chinese hamster ovary cell line CHO-derived recombinant human IL-28B/IFN-lambda 3, Arg30-Val200 (Lys74Arg), Accession No. Q81Z19
25 μg
282617.0
Reconstitute at 0.5 mg/mL in sterile PBS.
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month, 2 to 8°C under sterile conditions after reconstitution. 6 months, -20 to -70°C under sterile conditions after reconstitution.
IgG2a
ELISA
567108
ELISA
Q81Z19
Mouse
Protein A or G purified from hybridoma culture supernatant
Primary
Detects human IL-28B/IFN-lambda 3 in direct ELISAs.
Human
Supernatant
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.